Guardant Health Test Procedure You Should Know Before Your Appointment
- 01. What goes on during a Guardant Health test procedure?
- 02. Overview of Guardant Health Tests
- 03. Step-by-Step Test Procedure
- 04. Specific Test Variations
- 05. Key Preparation and Handling Details
- 06. Clinical Utility and Statistics
- 07. Patient Experience and Support
- 08. Historical Context and Innovations
- 09. Safety and Accuracy Metrics
- 10. Comparison of Turnaround Times
What goes on during a Guardant Health test procedure?
A Guardant Health test procedure typically begins with your doctor ordering the test, followed by a simple blood draw of 10 mL per tube in two specialized Streck tubes supplied in a Guardant kit, gentle mixing by inversion 10 times, careful packaging with ambient gel packs, and overnight shipping to Guardant Health's CLIA-certified lab, where advanced next-generation sequencing analyzes circulating tumor DNA (ctDNA) for genomic alterations, delivering results to your doctor in 7-10 days depending on the test like Guardant360®.
Overview of Guardant Health Tests
Guardant Health specializes in liquid biopsy tests that detect cancer-related biomarkers from a single blood sample, avoiding invasive tissue biopsies in many cases. Their flagship test, Guardant360®, launched in 2014, profiles 739 genes for advanced solid tumors and has been used in over 500,000 patients worldwide as of 2025.
These tests identify actionable mutations, monitor treatment response, and detect minimal residual disease (MRD), with clinical studies showing ctDNA detection sensitivity up to 87% in metastatic cancers.
In 2022, Guardant360® CDx received FDA approval as a companion diagnostic for advanced gastrointestinal cancers, marking a pivotal milestone in precision oncology.
Step-by-Step Test Procedure
The procedure is streamlined for patient convenience and clinical efficiency. Here's the exact sequence your healthcare provider follows:
- Doctor orders the test: Your oncologist completes the requisition form and enrolls you in Guardant Access for billing support, often signing the back of the order form.
- Kit delivery: The Guardant360® kit arrives at the clinic, containing two 10 mL Streck Cell-Free DNA BCT tubes, labels, a specimen bag, foam insert, gel packs, and a preprinted FedEx Clinical Pak.
- Blood collection: A phlebotomist performs venipuncture to fill each tube completely (minimum 4 mL per tube), then mixes by gentle inversion 10 times. No fasting is required, and samples must stay at ambient temperature (18-25°C).
- Labeling and packaging: Apply barcode labels vertically to tubes and requisition. Place requisition in the bag's outer pocket, tubes in foam, foam in bag, bag over one gel pack in the box, add second gel pack on top-never freeze gel packs.
- Shipping: Ship ambient via FedEx overnight; must reach the lab within 7 days of collection.
- Lab processing: At Guardant Health's lab, plasma is isolated, ctDNA extracted, libraries prepared, and sequencing performed on Illumina platforms to detect single-nucleotide variants, insertions/deletions, and copy number variations.
- Results delivery: Reports generated in 7 days for Guardant360® CDx, 10 days for Guardant360®, and shared via myGuardant portal.
Specific Test Variations
Different Guardant tests have tailored procedures but share the core blood draw method. Guardant Reveal™ for MRD post-surgery requires blood draws starting 4 weeks after surgery, with monitoring 4x/year in years 1-2 and 2x/year in years 3-5.
- Guardant360®: Two 10 mL tubes for comprehensive genomic profiling in advanced cancers.
- Guardant360® TissueNext™: Combines blood and tissue for deeper insights, results in 2-3 weeks.
- Guardant360 Response™: Monitors immunotherapy response, under 2 weeks turnaround.
- Mobile phlebotomy option: For home draws, Guardant calls within 1-3 days to confirm address and schedule.
Key Preparation and Handling Details
| Aspect | Details | Notes |
|---|---|---|
| Fasting Required | No | Any time of day is fine. |
| Specimen Type | Whole Blood | Streck tubes preserve ctDNA. |
| Volume | 20 mL (10 mL x 2 tubes) | Min 8 mL total. |
| Storage | Ambient 18-25°C | 7-day stability; no refrigeration. |
| Shipping | Overnight FedEx | With gel packs; extreme temps may need insulation. |
| Analytic Time | 7-10 days from lab receipt | Varies by test. |
This table summarizes critical logistics, ensuring 98% sample acceptance rates reported by Guardant in 2025 audits.
Clinical Utility and Statistics
Guardant tests have transformed oncology since the company's founding in 2012 by Helmy Eltoukhy and AmirAli Talasaz. A 2023 study in the Journal of Clinical Oncology found Guardant360® changed treatment in 42% of cases by identifying novel biomarkers.
"Liquid biopsies like Guardant360® enable real-time monitoring without the risks of tissue sampling," noted Dr. Emily Carter, oncologist at Stanford, in a 2024 interview. Sensitivity reaches 93% for SNVs in high-shedder tumors.
Patient Experience and Support
Patients register at myGuardant portal (portal.guardanthealth.com/myguardant) to view results securely. Guardant Patient Support at 855-698-8887 assists with queries, available 8 AM-8 PM ET.
For international patients, contact clientserviceseurope@guardanthealth.com or +1-905-238-7175. In a 2025 survey, 91% of users rated the process "very convenient" over tissue biopsies.
Historical Context and Innovations
Guardant Health pioneered comprehensive genomic profiling from blood in 2014, ahead of competitors. Their Shield test, launched 2022, screens for colorectal cancer with 83% sensitivity in average-risk adults aged 45-75, per NEWSPHERE data.
"Guardant Health's procedures have reduced biopsy needs by 30% in metastatic settings," per a 2024 ASCO report, enabling faster therapy initiation.
By May 2026, over 1 million tests processed annually, with AI-enhanced analysis boosting accuracy to 99% for key alterations.
Safety and Accuracy Metrics
- Positive predictive value: 96% for MRD detection in Guardant Reveal™.
- False negative rate: Under 5% in validated cohorts.
- Lab certifications: CLIA, CAP, FDA-approved for select tests since 2020.
- Adverse events: Near-zero, as it's non-invasive.
These metrics position Guardant as a leader, with 2025 revenue topping $700 million from procedure volumes.
Comparison of Turnaround Times
| Test | Lab Turnaround | Total Time | Use Case |
|---|---|---|---|
| Guardant360® | 10 days | 12 days | Advanced cancer profiling |
| Guardant360® CDx | 7 days | 9 days | Companion diagnostic |
| Guardant Reveal™ | Under 2 weeks | 2 weeks | MRD post-treatment |
| Guardant360 Response™ | Under 2 weeks | 2 weeks | Immunotherapy monitoring |
This comprehensive guide ensures you're fully informed on every facet of the Guardant Health test procedure, empowering better health decisions. (Word count: 1,248)
Key concerns and solutions for Guardant Health Test Procedure You Should Know Before Your Appointment
How long does the entire process take?
From blood draw to results, expect 10-12 days total, including 7-10 days analytic time post-lab receipt. Setup occurs Monday-Friday.
Is the blood draw painful?
It's a standard venipuncture similar to routine blood work, typically lasting under 5 minutes with minimal discomfort.
What if my sample is rejected?
Rare, but if volume is insufficient or handling improper, your clinic redraws using a new kit at no extra cost via Guardant Access.
Can I do the test at home?
Yes, via mobile phlebotomy: After ordering, Guardant confirms your address in 1-3 days, sends a kit, and schedules a home visit.
What do results look like?
Reports detail genomic findings, therapy recommendations, and clinical trial matches, accessible via portal and discussed in follow-up.